1. Home
  2. TMDX vs RNST Comparison

TMDX vs RNST Comparison

Compare TMDX & RNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • RNST
  • Stock Information
  • Founded
  • TMDX 1998
  • RNST 1904
  • Country
  • TMDX United States
  • RNST United States
  • Employees
  • TMDX N/A
  • RNST N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • RNST Major Banks
  • Sector
  • TMDX Health Care
  • RNST Finance
  • Exchange
  • TMDX Nasdaq
  • RNST Nasdaq
  • Market Cap
  • TMDX 3.9B
  • RNST 3.7B
  • IPO Year
  • TMDX 2019
  • RNST N/A
  • Fundamental
  • Price
  • TMDX $115.69
  • RNST $36.81
  • Analyst Decision
  • TMDX Buy
  • RNST Buy
  • Analyst Count
  • TMDX 11
  • RNST 6
  • Target Price
  • TMDX $125.40
  • RNST $43.80
  • AVG Volume (30 Days)
  • TMDX 958.8K
  • RNST 567.8K
  • Earning Date
  • TMDX 10-27-2025
  • RNST 10-21-2025
  • Dividend Yield
  • TMDX N/A
  • RNST 2.39%
  • EPS Growth
  • TMDX 2163.11
  • RNST N/A
  • EPS
  • TMDX 2.02
  • RNST 2.24
  • Revenue
  • TMDX $531,292,000.00
  • RNST $735,575,000.00
  • Revenue This Year
  • TMDX $38.87
  • RNST $42.66
  • Revenue Next Year
  • TMDX $20.70
  • RNST $12.60
  • P/E Ratio
  • TMDX $57.33
  • RNST $16.46
  • Revenue Growth
  • TMDX 48.09
  • RNST 17.23
  • 52 Week Low
  • TMDX $55.00
  • RNST $26.97
  • 52 Week High
  • TMDX $146.98
  • RNST $40.40
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 49.53
  • RNST 42.15
  • Support Level
  • TMDX $109.77
  • RNST $36.01
  • Resistance Level
  • TMDX $115.90
  • RNST $37.63
  • Average True Range (ATR)
  • TMDX 4.84
  • RNST 0.80
  • MACD
  • TMDX -0.12
  • RNST -0.17
  • Stochastic Oscillator
  • TMDX 31.21
  • RNST 27.68

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.

Share on Social Networks: